S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.18 (-0.49%)
MSFT   404.76 (-1.72%)
META   503.07 (+1.80%)
GOOGL   156.34 (+0.56%)
AMZN   179.53 (-0.97%)
TSLA   150.26 (-3.34%)
NVDA   849.38 (+1.07%)
AMD   154.91 (+0.58%)
NIO   4.01 (+2.56%)
BABA   68.98 (+0.23%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.72 (-3.10%)
GE   154.05 (-1.04%)
CGC   7.78 (+19.88%)
DIS   112.83 (-0.10%)
AMC   2.93 (-1.68%)
PFE   25.37 (-0.20%)
PYPL   62.11 (-1.82%)
XOM   118.50 (-0.11%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.18 (-0.49%)
MSFT   404.76 (-1.72%)
META   503.07 (+1.80%)
GOOGL   156.34 (+0.56%)
AMZN   179.53 (-0.97%)
TSLA   150.26 (-3.34%)
NVDA   849.38 (+1.07%)
AMD   154.91 (+0.58%)
NIO   4.01 (+2.56%)
BABA   68.98 (+0.23%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.72 (-3.10%)
GE   154.05 (-1.04%)
CGC   7.78 (+19.88%)
DIS   112.83 (-0.10%)
AMC   2.93 (-1.68%)
PFE   25.37 (-0.20%)
PYPL   62.11 (-1.82%)
XOM   118.50 (-0.11%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.18 (-0.49%)
MSFT   404.76 (-1.72%)
META   503.07 (+1.80%)
GOOGL   156.34 (+0.56%)
AMZN   179.53 (-0.97%)
TSLA   150.26 (-3.34%)
NVDA   849.38 (+1.07%)
AMD   154.91 (+0.58%)
NIO   4.01 (+2.56%)
BABA   68.98 (+0.23%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.72 (-3.10%)
GE   154.05 (-1.04%)
CGC   7.78 (+19.88%)
DIS   112.83 (-0.10%)
AMC   2.93 (-1.68%)
PFE   25.37 (-0.20%)
PYPL   62.11 (-1.82%)
XOM   118.50 (-0.11%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.18 (-0.49%)
MSFT   404.76 (-1.72%)
META   503.07 (+1.80%)
GOOGL   156.34 (+0.56%)
AMZN   179.53 (-0.97%)
TSLA   150.26 (-3.34%)
NVDA   849.38 (+1.07%)
AMD   154.91 (+0.58%)
NIO   4.01 (+2.56%)
BABA   68.98 (+0.23%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.72 (-3.10%)
GE   154.05 (-1.04%)
CGC   7.78 (+19.88%)
DIS   112.83 (-0.10%)
AMC   2.93 (-1.68%)
PFE   25.37 (-0.20%)
PYPL   62.11 (-1.82%)
XOM   118.50 (-0.11%)
NASDAQ:EYE

National Vision (EYE) Stock Price, News & Analysis

$18.82
-0.16 (-0.84%)
(As of 03:45 PM ET)
Today's Range
$18.75
$19.29
50-Day Range
$18.88
$23.81
52-Week Range
$13.71
$27.02
Volume
391,991 shs
Average Volume
967,661 shs
Market Capitalization
$1.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.86

National Vision MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
25.3% Upside
$23.86 Price Target
Short Interest
Bearish
11.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.35
Upright™ Environmental Score
News Sentiment
0.04mentions of National Vision in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
51.61%
From $0.31 to $0.47 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.24 out of 5 stars

Medical Sector

293rd out of 914 stocks

Ophthalmic Goods Industry

3rd out of 7 stocks

EYE stock logo

About National Vision Stock (NASDAQ:EYE)

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

EYE Stock Price History

EYE Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
EYE Apr 2024 25.000 put
See More Headlines
Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/18/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
N/A
Current Symbol
NASDAQ:EYE
Fax
N/A
Employees
13,998
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.86
High Stock Price Target
$34.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+26.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-65,900,000.00
Pretax Margin
-2.90%

Debt

Sales & Book Value

Annual Sales
$2.13 billion
Cash Flow
$1.75 per share
Book Value
$10.60 per share

Miscellaneous

Free Float
76,668,000
Market Cap
$1.47 billion
Optionable
Optionable
Beta
1.39
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives


EYE Stock Analysis - Frequently Asked Questions

Should I buy or sell National Vision stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" EYE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EYE, but not buy additional shares or sell existing shares.
View EYE analyst ratings
or view top-rated stocks.

What is National Vision's stock price target for 2024?

5 brokers have issued 1-year price objectives for National Vision's stock. Their EYE share price targets range from $19.00 to $34.00. On average, they expect the company's share price to reach $23.86 in the next twelve months. This suggests a possible upside of 25.3% from the stock's current price.
View analysts price targets for EYE
or view top-rated stocks among Wall Street analysts.

How have EYE shares performed in 2024?

National Vision's stock was trading at $20.93 at the beginning of 2024. Since then, EYE shares have decreased by 9.0% and is now trading at $19.04.
View the best growth stocks for 2024 here
.

When is National Vision's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our EYE earnings forecast
.

How were National Vision's earnings last quarter?

National Vision Holdings, Inc. (NASDAQ:EYE) announced its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.07. The business earned $506.40 million during the quarter, compared to analysts' expectations of $499.49 million. National Vision had a negative net margin of 3.10% and a positive trailing twelve-month return on equity of 3.69%. The business's quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.11) EPS.

What ETFs hold National Vision's stock?

ETFs with the largest weight of National Vision (NASDAQ:EYE) stock in their portfolio include Invesco S&P SmallCap Consumer Discretionary ETF (PSCD) and SPDR S&P 600 Small Cap ETF (SLY).Ranger Equity Bear ETF (HDGE).

What guidance has National Vision issued on next quarter's earnings?

National Vision issued an update on its FY24 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of $0.50-$0.65 for the period, compared to the consensus earnings per share estimate of $0.56. The company issued revenue guidance of $1.965-$2.005 billion, compared to the consensus revenue estimate of $1.94 billion.

What is L. Reade Fahs' approval rating as National Vision's CEO?

243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of National Vision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Vision investors own include Verizon Communications (VZ), Enterprise Products Partners (EPD), AT&T (T), Carnival Co. & (CCL), Antares Pharma (ATRS), Advanced Micro Devices (AMD), Gilead Sciences (GILD), QUALCOMM (QCOM), Tanger (SKT) and STMicroelectronics (STM).

When did National Vision IPO?

National Vision (EYE) raised $300 million in an IPO on Thursday, October 26th 2017. The company issued 15,800,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

How do I buy shares of National Vision?

Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EYE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners